TEVA PHARMACEUTICAL INDUSTRIES LTD Insider Trading for February 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in TEVA PHARMACEUTICAL INDUSTRIES LTD.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in TEVA PHARMACEUTICAL INDUSTRIES LTD for February 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 20 2018 | TEVA | TEVA PHARMACEUTICA ... | Sabag Mark | EVP, Global Human R ... | Sell | S | 20.52 | 3,000 | 61,560 | 41,517 | 44.5 K to 41.5 K (-6.74 %) |
| Feb 20 2018 | TEVA | TEVA PHARMACEUTICA ... | Sabag Mark | EVP, Global Human R ... | Sell | S | 18.45 | 2,050 | 37,823 | 44,517 | 46.6 K to 44.5 K (-4.40 %) |
| Feb 12 2018 | TEVA | TEVA PHARMACEUTICA ... | Codner Iris Beck | EVP Global Brand&Co ... | Option Exercise | A | 0.00 | 34,031 | 0 | 34,031 | |
| Feb 12 2018 | TEVA | TEVA PHARMACEUTICA ... | Codner Iris Beck | EVP Global Brand&Co ... | Option Exercise | A | 18.61 | 86,762 | 1,614,641 | 86,762 | |
| Feb 12 2018 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Option Exercise | A | 0.00 | 37,614 | 0 | 37,614 | |
| Feb 12 2018 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Option Exercise | A | 18.61 | 95,890 | 1,784,513 | 95,890 | |
| Feb 12 2018 | TEVA | TEVA PHARMACEUTICA ... | O'Grady Brendan P. | EVP, North America ... | Option Exercise | A | 0.00 | 48,361 | 0 | 48,361 | |
| Feb 12 2018 | TEVA | TEVA PHARMACEUTICA ... | O'Grady Brendan P. | EVP, North America ... | Option Exercise | A | 18.61 | 123,288 | 2,294,390 | 123,288 | |
| Feb 12 2018 | TEVA | TEVA PHARMACEUTICA ... | McClellan Michael James | EVP, Chief Financia ... | Option Exercise | A | 0.00 | 48,361 | 0 | 48,361 | |
| Feb 12 2018 | TEVA | TEVA PHARMACEUTICA ... | McClellan Michael James | EVP, Chief Financia ... | Option Exercise | A | 18.61 | 123,288 | 2,294,390 | 123,288 | |
| Feb 12 2018 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | A | 0.00 | 48,361 | 0 | 48,361 | |
| Feb 12 2018 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | A | 18.61 | 123,288 | 2,294,390 | 123,288 | |
| Feb 12 2018 | TEVA | TEVA PHARMACEUTICA ... | Dethlefs Sven | EVP Global Marketin ... | Option Exercise | A | 0.00 | 39,405 | 0 | 39,405 | |
| Feb 12 2018 | TEVA | TEVA PHARMACEUTICA ... | Dethlefs Sven | EVP Global Marketin ... | Option Exercise | A | 18.61 | 100,457 | 1,869,505 | 100,457 | |
| Feb 12 2018 | TEVA | TEVA PHARMACEUTICA ... | de Notaristefani Carlo | Executive VP Global ... | Option Exercise | A | 0.00 | 62,690 | 0 | 62,690 | |
| Feb 12 2018 | TEVA | TEVA PHARMACEUTICA ... | de Notaristefani Carlo | Executive VP Global ... | Option Exercise | A | 18.61 | 159,819 | 2,974,232 | 159,819 | |
| Feb 12 2018 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Option Exercise | A | 0.00 | 39,405 | 0 | 39,405 | |
| Feb 12 2018 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Option Exercise | A | 18.61 | 100,457 | 1,869,505 | 100,457 |